Suppr超能文献

肢端肥大症:一项流行病学研究。

Acromegaly: an epidemiological study.

作者信息

Etxabe J, Gaztambide S, Latorre P, Vazquez J A

机构信息

Department of Endocrinology, Hospital de Cruces, Universidad del Paìs Vasco, Vizcaya, Spain.

出版信息

J Endocrinol Invest. 1993 Mar;16(3):181-7. doi: 10.1007/BF03344942.

Abstract

Although morbility and mortality in acromegaly are higher than in the general population, there have been very few previous epidemiological studies. This study tries to answer "why". Seventy-four patients affected by acromegaly in Vizcaya (Spain) between 1970 and 1989 were considered for an epidemiological study. The prevalence of known cases at the end of 1989 was 60 per million inhabitants. The average incidence of newly diagnosed cases was 3.1 per million people per year. Unexpectedly, acromegaly was more frequent in women (n = 48) than in men (n = 26), with a ratio of 1.8:1. Mean age at diagnosis was significantly higher in women (46.1 +/- 2.2 yr) than in men (39.5 +/- 2.2 yr) (p < 0.05) There was a positive correlation between age at diagnosis and the estimated duration of the disease (r = 0.56, p < 0.05) and a negative one between age and basal GH serum levels (r = -0.52 p < 0.002). The age at diagnosis was significantly higher in patients with invasive tumors (grade III and IV) than in those with enclosed tumors (grade I and II) (47.7 +/- 1.8 vs 40.1 +/- 3.3 p < 0.05). In general, mortality was higher than the expected for the control population (standardized mortality ratio, SMR = 3.2, 95% confidence interval. Cl = 1.55-5.93). However, mortality was higher in men (SMR = 7, 95% Cl = 2.81-14.4) but not in women (SMR = 1.4 95% Cl = 0.29-4.17).(ABSTRACT TRUNCATED AT 250 WORDS)

摘要

尽管肢端肥大症患者的发病率和死亡率高于普通人群,但此前的流行病学研究却非常少。本研究试图回答“原因何在”。1970年至1989年间,西班牙比斯开省的74例肢端肥大症患者被纳入一项流行病学研究。1989年底已知病例的患病率为每百万居民60例。新诊断病例的平均发病率为每年每百万人3.1例。出乎意料的是,肢端肥大症在女性(n = 48)中比男性(n = 26)更常见,比例为1.8:1。女性的诊断平均年龄(46.1 +/- 2.2岁)显著高于男性(39.5 +/- 2.2岁)(p < 0.05)。诊断年龄与疾病估计病程之间呈正相关(r = 0.56,p < 0.05),而年龄与基础生长激素血清水平之间呈负相关(r = -0.52,p < 0.002)。侵袭性肿瘤(III级和IV级)患者的诊断年龄显著高于包膜完整肿瘤(I级和II级)患者(47.7 +/- 1.8岁对40.1 +/- 3.3岁,p < 0.05)。总体而言,死亡率高于对照组人群的预期(标准化死亡率,SMR = 3.2,95%置信区间,Cl = 1.55 - 5.93)。然而,男性的死亡率更高(SMR = 7,95% Cl = 2.81 - 14.4),而女性并非如此(SMR = 1.4,95% Cl = 0.29 - 4.17)。(摘要截取自250字)

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验